• Saudi Arabia-based healthtech Thakaa Med has secured a Seed round investment through Falak Angels syndicate. 
• Founded in 2022 by Alwaleed Albadr, ThakaaMed specialises in AI-driven healthcare solutions, focussing on transforming care through advanced predictive, preventive, and personalised technologies.
• This capital will be used to accelerate the enhancement of Thakaa Med’s AI models and support the market launch of its flagship products, Dental IQ and Chest IQ.

Press release:

Thakaa Med, a leading AI-driven healthcare innovator and part of Falak Angels Alumni, has successfully secured its first seed round investment through a Falak Angels syndicate. This capital will be used to accelerate the enhancement of Thakaa Med’s AI models and support the market launch of its flagship products, Dental IQ and Chest IQ. This strategic investment is in line with Falak Angels' mission to empower startups at the forefront of technological innovation.

"Falak Angels remains committed to supporting the next generation of tech startups, providing them with both financial and strategic resources to ensure their growth and impact," said Adwa Aldakheel - CEO of Falak Investment Hub.

ThakaaMed plans to utilise this investment to advance its AI technologies, bringing innovative solutions to the healthcare sector, and contributing to the Kingdom’s Vision 2030.

ThakaaMed specialises in AI-driven healthcare solutions, focussing on transforming care through advanced predictive, preventive, and personalised technologies.

Falak Angels is an investment enabler, linking smart money with smart founders. With a portfolio of over 180 startup alumni, Falak Angels provides strategic support and capital to innovative startups across the MENA region.